Study shows new drug combination may benefit women with ER/PR-positive breast cancer
1,069 views · Published 10 December 2014 · 3:08 · Indexed 27 October 2026
Channel: Dana-Farber Cancer Institute · 2014 · Science & Technology
A new study led by Dr. Ian Krop, Medical Oncologist at the Susan F. Smith Center for Women’s Cancers at Dana-Farber shows new drug combination may benefit women with advanced ER/PR-positive breast cancer. Krop's research is being presented at the 2014 San Antonio Breast Cancer Symposium. Click here to learn more about Dana-Farber's participation at San Antonio: http://www.dana-farber.org/Adult-Care/Treatment-and-Support/Treatment-Centers-and-Clinical-Services/Susan-F--Smith-Center-for-Women-s-Cancers/San-Antonio-Breast-Cancer-Symposium.aspx
More from this channel
-
0:18
Importance of Joining the Stem Cell Registry | Dana-Farber Cancer Institute
-
0:20
How to Join the Stem Cell Registry | Dana-Farber Cancer Institute
-
0:18
How to Register as a Stem Cell Donor | Dana-Farber Cancer Institute
-
3:03
Sportscaster Jim Britt for the Jimmy Fund | Dana-Farber Cancer Institute
-
0:07
Dana-Farber Banners | Dana-Farber Cancer Institute
-
2:08
Barbers for the Jimmy Fund | Dana-Farber Cancer Institute
-
1:43
Pets | Dana-Farber Cancer Institute
-
1:34
Healthy Eating for the Holiday Season | Dana-Farber Cancer Institute